BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21416471)

  • 1. Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation.
    Kang J; Hur H; Min BS; Lee KY; Kim NK
    J Surg Oncol; 2011 Jul; 104(1):53-8. PubMed ID: 21416471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy.
    Leibold T; Shia J; Ruo L; Minsky BD; Akhurst T; Gollub MJ; Ginsberg MS; Larson S; Riedel E; Wong WD; Guillem JG
    J Clin Oncol; 2008 May; 26(13):2106-11. PubMed ID: 18362367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemoradiation may not always be needed for patients with T3 and T2N+ rectal cancer.
    Frasson M; Garcia-Granero E; Roda D; Flor-Lorente B; Roselló S; Esclapez P; Faus C; Navarro S; Campos S; Cervantes A
    Cancer; 2011 Jul; 117(14):3118-25. PubMed ID: 21264832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ; Liu MC; Jian JJ; Horng CF; Cheng TI; Chen CM; Fang WT; Chung YL
    Ann Surg Oncol; 2007 Oct; 14(10):2766-72. PubMed ID: 17551794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer.
    Peng J; Xu Y; Guan Z; Zhu J; Wang M; Cai G; Sheng W; Cai S
    Ann Surg Oncol; 2008 Nov; 15(11):3118-23. PubMed ID: 18769971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
    Guillem JG; Díaz-González JA; Minsky BD; Valentini V; Jeong SY; Rodriguez-Bigas MA; Coco C; Leon R; Hernandez-Lizoain JL; Aristu JJ; Riedel ER; Nitti D; Wong WD; Pucciarelli S
    J Clin Oncol; 2008 Jan; 26(3):368-73. PubMed ID: 18202411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy.
    Morcos B; Baker B; Al Masri M; Haddad H; Hashem S
    Eur J Surg Oncol; 2010 Apr; 36(4):345-9. PubMed ID: 20071133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CEA as a predictor for the response to preoperative chemoradiation in rectal cancer.
    Park YA; Sohn SK; Seong J; Baik SH; Lee KY; Kim NK; Cho CW
    J Surg Oncol; 2006 Feb; 93(2):145-50. PubMed ID: 16425302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.
    Tepper JE; O'Connell M; Hollis D; Niedzwiecki D; Cooke E; Mayer RJ;
    J Clin Oncol; 2003 Oct; 21(19):3623-8. PubMed ID: 14512393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
    Lombardi R; Cuicchi D; Pinto C; Di Fabio F; Iacopino B; Neri S; Tardio ML; Ceccarelli C; Lecce F; Ugolini G; Pini S; Di Tullio P; Taffurelli M; Minni F; Martoni A; Cola B
    Ann Surg Oncol; 2010 Mar; 17(3):838-45. PubMed ID: 20012700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.
    de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Geisler D; Dietz DW; Lavery IC; Fazio VW; Kalady MF
    Ann Surg Oncol; 2011 Jun; 18(6):1590-8. PubMed ID: 21207164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of preoperative chemoradiotherapy on advanced low rectal cancer.
    Kao PS; Chang SC; Wang LW; Lee RC; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Lin JK
    J Surg Oncol; 2010 Dec; 102(7):771-7. PubMed ID: 20872811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
    Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
    J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of fat clearance lymph node harvest for invasive rectal adenocarcinoma following neoadjuvant therapy.
    Wang H; Safar B; Wexner SD; Denoya P; Berho M
    Dis Colon Rectum; 2009 Oct; 52(10):1767-73. PubMed ID: 19966611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally advanced rectal cancer patients receiving radio-chemotherapy: a novel clinical-pathologic score correlates with global outcome.
    Berardi R; Mantello G; Scartozzi M; Del Prete S; Luppi G; Martinelli R; Fumagalli M; Grillo-Ruggieri F; Bearzi I; Mandolesi A; Marmorale C; Cascinu S
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1437-43. PubMed ID: 19386440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.